ES2084721T3 - Oximas de oleandomicina, su preparacion y uso. - Google Patents

Oximas de oleandomicina, su preparacion y uso.

Info

Publication number
ES2084721T3
ES2084721T3 ES91104231T ES91104231T ES2084721T3 ES 2084721 T3 ES2084721 T3 ES 2084721T3 ES 91104231 T ES91104231 T ES 91104231T ES 91104231 T ES91104231 T ES 91104231T ES 2084721 T3 ES2084721 T3 ES 2084721T3
Authority
ES
Spain
Prior art keywords
preparation
oximes
stands
oleandomicine
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91104231T
Other languages
English (en)
Inventor
Gorjana Lazarevski
Slobodan Djokic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pliva Farmaceutika dd
Original Assignee
Pliva Farmaceutska Kemijska Prehrambena I Kozmeticka Industrija dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Farmaceutska Kemijska Prehrambena I Kozmeticka Industrija dd filed Critical Pliva Farmaceutska Kemijska Prehrambena I Kozmeticka Industrija dd
Application granted granted Critical
Publication of ES2084721T3 publication Critical patent/ES2084721T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

OXIMAS DE OLEANDOMICINA EN DONDE R ELEVADO A 1 SE COLOCA POR HIDROGENO O -CH SUB 3, R (AL CUADRADO) SE COLOCA POR -CH SUB 3 O HIDROGENO O R ELEVADO A 1 Y R (AL CUADRADO) SE COLOCAN JUNTOS POR UN GRUPO EPOXIDO O POR =CH SUB 2, R ELEVADO A 3 SE COLOCA POR -OH, EN DONDE LA LINEA ONDULADA EQUIVALE A UNA BANDA INDIVIDUAL O UNA BANDA DOBLE, UN PROCESO PARA LA PREPARACION DE ESO Y SU USO EN LA OBTENCION DE AGENTES ANTIMICROBIALES.
ES91104231T 1990-03-21 1991-03-19 Oximas de oleandomicina, su preparacion y uso. Expired - Lifetime ES2084721T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU00556/90A YU55690A (en) 1990-03-21 1990-03-21 Process for preparing oleandomycin oxime

Publications (1)

Publication Number Publication Date
ES2084721T3 true ES2084721T3 (es) 1996-05-16

Family

ID=25550446

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91104231T Expired - Lifetime ES2084721T3 (es) 1990-03-21 1991-03-19 Oximas de oleandomicina, su preparacion y uso.

Country Status (21)

Country Link
US (1) US5268462A (es)
EP (1) EP0448035B1 (es)
JP (1) JP2763972B2 (es)
CN (1) CN1033645C (es)
AT (1) ATE132872T1 (es)
BG (1) BG60682B1 (es)
CA (1) CA2038629C (es)
CZ (1) CZ279898B6 (es)
DE (1) DE69116188T2 (es)
DK (1) DK0448035T3 (es)
ES (1) ES2084721T3 (es)
GR (1) GR3019113T3 (es)
HR (1) HRP920482B1 (es)
HU (2) HU207868B (es)
PL (1) PL166395B1 (es)
RO (1) RO111769B1 (es)
RU (1) RU2021281C1 (es)
SI (1) SI9010556B (es)
SK (1) SK279105B6 (es)
UA (1) UA26903C2 (es)
YU (1) YU55690A (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2275459A2 (fr) * 1974-06-21 1976-01-16 Aries Robert Nouveau derive de la rifamycine
US4063014A (en) * 1975-06-12 1977-12-13 Abbott Laboratories 4"-O-sulfonyl erythromycin-9-O-oxime derivatives
US4069379A (en) * 1976-07-08 1978-01-17 Pfizer Inc. Semi-synthetic oleandomycins
US4180654A (en) * 1978-01-03 1979-12-25 Pfizer Inc. 4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate
US4336368A (en) * 1981-04-20 1982-06-22 Pfizer Inc. 4 Deoxy-4-methylene oleandomycin and derivatives thereof
US4429116A (en) * 1982-12-27 1984-01-31 Pfizer Inc. Alkylated oleandomycin containing compounds
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体

Also Published As

Publication number Publication date
RU2021281C1 (ru) 1994-10-15
PL289507A1 (en) 1992-03-09
HRP920482A2 (en) 1994-08-31
EP0448035A1 (en) 1991-09-25
CA2038629A1 (en) 1991-09-22
SI9010556B (sl) 1998-10-31
HUT56848A (en) 1991-10-28
DE69116188D1 (de) 1996-02-22
SI9010556A (sl) 1998-04-30
CZ279898B6 (cs) 1995-08-16
DK0448035T3 (da) 1996-05-20
UA26903C2 (uk) 1999-12-29
US5268462A (en) 1993-12-07
DE69116188T2 (de) 1996-09-05
PL166395B1 (pl) 1995-05-31
JP2763972B2 (ja) 1998-06-11
HRP920482B1 (en) 1998-12-31
HU207868B (en) 1993-06-28
JPH04234896A (ja) 1992-08-24
SK279105B6 (sk) 1998-06-03
CA2038629C (en) 1996-09-10
ATE132872T1 (de) 1996-01-15
RO111769B1 (ro) 1997-01-30
YU55690A (en) 1990-12-31
CS9100768A2 (en) 1991-11-12
CN1033645C (zh) 1996-12-25
EP0448035B1 (en) 1996-01-10
BG60682B1 (bg) 1995-12-29
CN1054979A (zh) 1991-10-02
GR3019113T3 (en) 1996-05-31
HU211574A9 (en) 1995-12-28

Similar Documents

Publication Publication Date Title
CA2041260A1 (en) Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents
MD1233C2 (ro) Derivaţi de eritromicină, procedeu de preparare a lor şi compoziţie farmaceutică pe baza acestora
MY121908A (en) 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them.
MX9805181A (es) Derivados de lactona a partir de derivados de 17.beta- carboxi, carbotio y amida androstano.
JPS5645452A (en) Noxious organism repellant
IL69730A0 (en) Substituted azolylalkyl-t-butyl-ketones and-carbinols,their preparation and their use as plant protection agents
DK0443848T3 (da) Nyt antiulcermiddel
YU48671B (sh) Novi derivati beta-fenilizoserina, njegovo dobijanje i primena
CA2047802A1 (en) Pharmaceutical compositions
HUT50787A (en) Process for producing pharmaceutical compositions comprising 4-aryl-4-piperidine-, pyrrolidine- or hexahydroazepincarbinol derivatives or heterocyclic analogs thereof as active ingredient and process for producing the new compounds
ES2084721T3 (es) Oximas de oleandomicina, su preparacion y uso.
GR3031118T3 (en) Novel seco-D steroids active in the cardiovascular system and pharmaceutical compositions containing same
FR2659620B1 (fr) Banc d'entrainement au parachutisme.
ATE125270T1 (de) Tert-butyloxycarbonyl-l-tyrosyl- peptidoglycanmonomer und deren 125 i-markiertes derivat, deren herstellung und verwendung.
IL78080A0 (en) Piperazinylmethyl-1,2,4-triazolylmethyl-carbinols,their preparation and their use as plant protecting agents
ES8703855A1 (es) Procedimiento para la obtencion de derivados de sulfonilgua-nidinotriazina
GR74782B (es)
CA2077618A1 (en) N1-trifluoroalkyl substituted 2-nitro-p-phenylenediamine dyes
CA2069614A1 (en) Low molecular weight copolymer amides
TW279783B (es)
Palani Professor Dr. N. Subbu Reddiar's contributions for the enrichment of Tamil
ITRM920498A0 (it) Composizione per l'ignifugazione delle materie polimere.
BR9004950A (pt) Composicoes azeotropicas ternarias de 1,1-dicloro-1,2-difluoroetano e trans-1,2-dicloroetileno com metanol,etanol ou isopropanol
ES8606298A1 (es) 1.4-dihidropirazinas
IT231227Y1 (it) Supporto perfezionato per l'uso del filo interdentale

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 448035

Country of ref document: ES